×

Intellectual Property Patents

  • Allergan's unusual patent agreement

    CNBC's Meg Tirrell reports on senators commenting on Allergan's patent agreement with the Saint Regis Mohawk Tribe.

  • Allergan's Restasis medicine for dry eyes.

    Allergan is urging the Senate Judiciary Committee to review the patent challenge system it’s been accused of thwarting.

  • The Allergan post at the New York Stock Exchange.

    Senator Claire McCaskill late Monday called Allergan's deal a "brazen loophole" she says should be illegal.

  • TORONTO, Oct 2- The man who was leading BlackBerry Ltd's efforts to make money from its patent portfolio has left to join a health technology company, two sources with knowledge of the move said on Monday. Mark Kokes left the Canadian company last month to join privately held NantWorks LLC, the sources said. NantWorks was founded in 2011 by billionaire Patrick...

  • BRUSSELS, Oct 2- The European Union is drawing up guidelines on how much patent holders should charge for their technologies, a thorny issue that pits Apple and other users against Qualcomm and Ericsson. The patent fee model used by world No. 1 smartphone chip designer Qualcomm predominates in the tech industry and is based on how much value a technology adds to a...

  • BRUSSELS, Oct 2- The European Union is drawing up guidelines on how much patent holders should charge for their technologies, a thorny issue that pits Apple and other users against Qualcomm and Ericsson. The patent fee model used by world No. 1 smartphone chip designer Qualcomm, which bases royalties on a product's total cost, predominates in the tech industry but...

  • WASHINGTON, Sept 27- The U.S. International Trade Commission has agreed to probe certain Wi-Fi enabled devices and their parts after Japan's Sharp Corp accused China's Hisense Group Co Ltd of infringing its patents, the body said on Wednesday. Sharp, which had licensed Hisense to use the brand to sell televisions in the United States, sued the Chinese...

  • Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds that the board has no jurisdiction over the tribe. In its court filing on Friday, the tribe said it is sovereign government that cannot face litigation in an administrative court...

  • Sept 22- A Native American tribe holding patents for drugmaker Allergan Plc on Friday moved to dismiss a case brought by generic drug company Mylan NV challenging the patents. Patent Trial and Appeal Board, the Saint Regis Mohawk Tribe asked that Mylan's case seeking to invalidate Allergan's patents on dry-eye medicine Restasis be thrown out on the grounds...

  • ST REGIS MOHAWK TRIBE MOVES TO DISMISS MYLAN CHALLENGE TO ALLERGAN PATENTS- FILING.

  • TRIBE SAYS ITS SOVEREIGN STATUS IMMUNIZES RESTASIS PATENTS FROM U.S.

  • HELSINKI, Sept 18- Nokia will start to book additional revenue from the current quarter after a ruling by an arbitration court on payments from South Korea's LG Electronics for using its smartphone patents. We continue to see potential for additional licensing opportunities, "said Nokia Chief Legal Officer Maria Varsellona in a statement.

  • The Ohio Democrat said he will look at how Congress can "close loopholes that drug companies exploit to avoid competition. Allergan said it has reached out to Brown's office "to provide the facts and context around this agreement with the Saint Regis Mohawk Tribe." Allergan said on Sept. 8 it will transfer patents relating to its dry-eye medicine Restasis to the...

  • The Ohio Democrat said he will look at how Congress can "close loopholes that drug companies exploit to avoid competition. Allergan said it has reached out to Brown's office "to provide the facts and context around this agreement with the Saint Regis Mohawk Tribe." Allergan said on Sept. 8 it will transfer patents relating to its dry-eye medicine Restasis to the...

  • Reddy's, Allergan Plc's Actavis Laboratories, Endo International's Par Pharmaceutical, Alvogen Pharma US, Teva Pharmaceutical Industries and Mylan NV. The lawsuits allege that these companies have infringed a patent that relates to an oral film containing buprenorphine and naloxone, the key constituents of Suboxone, the London- listed drugmaker said in a...

  • Sept 13- As generic drug manufacturers are. Last week, Allergan announced it would transfer the patent rights to its Restasis dry-eye treatment to the Saint Regis Mohawk Tribe, which will license them back to the company in exchange for ongoing payments. But Richard Torczon, a lawyer for generic drug company Mylan.

  • Patent and Trademark Office records, SRC Labs LLC on Aug. 2 transferred around 40 patents to the St. Regis Mohawk Tribe. The deals announced so far "are just the tip of the iceberg," said David Pridham, chief executive of Dominion Harbor Group, a Dallas- based firm that advises patent owners on monetization efforts. Headed by Dallas lawyer, entrepreneur and investment...

  • NEW YORK, Sept 12- Generic drugmaker Mylan NV alleged in a court filing that rival Allergan Plc is trying to take advantage of Native American sovereignty to shield its patent for the blockbuster dry-eye treatment Restasis. In Federal District Court in Marshall, Texas, on Monday, Mylan said Allergan is "attempting to misuse Native American sovereignty to shield...

  • Sept 12- A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition. Allergan said on Friday it had transferred patents on its blockbuster dry...

  • Sept 11- A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts said, potentially dealing a blow to generic competition. Allergan said on Friday it had transferred patents on its blockbuster dry...